Sopivina

Sopivina, commonly written as sopivacaine in many languages, is an amide-type local anesthetic used to produce regional anesthesia. It acts by reversibly blocking voltage-gated sodium channels on nerve membranes, thereby preventing the initiation and propagation of nerve impulses.

Clinically, sopivina is employed for infiltration anesthesia, peripheral nerve blocks, epidural anesthesia, and other regional techniques during surgical procedures or obstetric anesthesia. It is typically delivered by injection near the target nerves or within the operative field and may be administered alone or with a vasoconstrictor such as epinephrine to prolong its effect and reduce systemic absorption.

Pharmacokinetically, sopivina is absorbed from the site of administration into the bloodstream and is distributed to tissues before being metabolized primarily in the liver by amidases and, to a lesser extent, cytochrome P450 enzymes. Onset of anesthesia generally occurs within minutes, and the duration lasts several hours depending on dose, concentration, and technique.

Adverse effects are similar to other amide local anesthetics and can include CNS symptoms such as lightheadedness or tinnitus at high plasma levels, as well as hypotension and, in rare cases, cardiotoxicity. Allergic reactions to amide anesthetics are uncommon. Careful dosing, consideration of hepatic function, and appropriate monitoring are advised.

Sopivina is valued for producing a sensory-dominant block with comparatively reduced motor impairment relative to some agents, a feature that can be advantageous in certain regional anesthesia contexts. Related agents include lidocaine, mepivacaine, and bupivacaine.